ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15.

K. Atiemo,1 H. Maddur,1 L. Zhao,1 A. Skaro,2 S. Montag,1 L. VanWagner,1 S. Goel,1 A. Kho,1 R. Kang,1 J. Holl,1 M. Abecassis,1 J. Levitsky,1 L. Kulik,1 D. Ladner.1

1Northwestern University Transplant Research Collaborative, Chicago
2London Health Sciences Center, London, ON, Canada

Meeting: 2017 American Transplant Congress

Abstract number: C190

Keywords: Mortality, Multicenter studies, Multivariate analysis

Session Information

Session Name: Poster Session C: Organ Allocation, Meld Score, Organ Utilization, and Transplant Outcomes

Session Type: Poster Session

Date: Monday, May 1, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Introduction:Subpopulations of patients with liver cirrhosis exist for whom the Model for End-Stage Liver Disease Sodium Score (MELDNa) is suboptimal for mortality prediction and who may benefit from liver transplantation. We examine whether racial differences in liver cirrhosis related mortality are observed in these subpopulations.

Methods: We used aggregated EHR data from 5 academic centers and 1 county healthcare system in the greater Chicago area (HealthLNK) which contains data on patients followed from Jan 2006 to Dec 2012. Patients with liver cirrhosis were identified using ICD-9 codes 571.2, 571.5 and 571.6. Those with a maximum MELDNa scores ≤ 15 were stratified according to race-white or black. Analysis employed a cox model with interaction terms.

Results: Longitudinal data about 5,126 adult patients with cirrhosis were used. Of these, 2017 (39%) patients had a maximum MELDNa score ≤15. 1316 (65%) were white. 701 (35%) were black. 1 year 3 year and 5 year mortality among white patients was 3.5%, 11.3% and 16.5% respectively. Among black patients it was 5.9%, 12% and 20% respectively. The difference in mortality was not statistically significant (p=0.08). Using a multivariate cox proportional hazards model, severe hypoalbuminemia (maximum serum albumin <2.8g/dL) (HR 4.9 ; CI 3.3-7.2), hepatorenal syndrome (HR 3.9; CI 1.4-11.0), moderate hypoalbuminemia (maximum serum albumin 2.8-3.5 g/dL) (HR 2.9; CI 2.1-4.0), ascites (HR 1.7 ; CI 1.3-2.4) hepatic hydrothorax (HR 1.7; CI 1.1-2.7) and malnutrition (HR 1.5; CI 1.02-2.15), were associated with an increased risk of death, independent of MELDNa score. When interaction terms were introduced into the cox model the effect of severe hypoalbuminemia was noted to differ by race (p=0.0076). White patients with severe hypoalbuminemia had a HR of 7.8 (CI 4.8-12.7) while black patients had a HR of 2.8 (CI 1.5-5.1). Racial differences were not observed for moderate hypoalbuminemia, ascites, hepatic hydrothorax and malnutrition.

Conclusion:

Among patients with MELDNa ≤15, severe hypoalbuminemia confers a more than 2 1/2 increased risk of death for white compared to black patients. These results can inform decisions regarding treatments including liver transplantation.

CITATION INFORMATION: Atiemo K, Maddur H, Zhao L, Skaro A, Montag S, VanWagner L, Goel S, Kho A, Kang R, Holl J, Abecassis M, Levitsky J, Kulik L, Ladner D. Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Atiemo K, Maddur H, Zhao L, Skaro A, Montag S, VanWagner L, Goel S, Kho A, Kang R, Holl J, Abecassis M, Levitsky J, Kulik L, Ladner D. Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/racial-differences-in-liver-cirrhosis-related-mortality-among-patients-with-model-for-end-stage-liver-disease-sodium-score-meldna-15/. Accessed May 25, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences